Grandeur Peak Global Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.09M Sell
135,646
-22,547
-14% -$1.35M 1.66% 14
2025
Q4
$9.3M Buy
158,193
+1,832
+1% +$111K 1.25% 19
2025
Q3
$8.7M Buy
156,361
+17,847
+13% +$956K 1.17% 21
2025
Q2
$7.13M Buy
138,514
+90,139
+186% +$4.53M 0.86% 33
2025
Q1
$2.84M Buy
48,375
+43,250
+844% +$2.93M 0.31% 67
2024
Q4
$369K Sell
5,125
-6,844
-57% -$503K 0.03% 120
2024
Q3
$957K Sell
11,969
-2,700
-18% -$203K 0.08% 105
2024
Q2
$1.05M Sell
14,669
-1,732
-11% -$127K 0.08% 97
2024
Q1
$1.15M Hold
16,401
0.09% 94
2023
Q4
$1.27M Buy
16,401
+1,811
+12% +$119K 0.09% 91
2023
Q3
$993K Sell
14,590
-12,547
-46% -$991K 0.07% 91
2023
Q2
$2.22M Buy
27,137
+5,755
+27% +$463K 0.15% 77
2023
Q1
$1.59M Sell
21,382
-15,574
-42% -$1.2M 0.1% 78
2022
Q4
$3.06M Sell
36,956
-2,000
-5% -$159K 0.18% 61
2022
Q3
$2.77M Buy
+38,956
New +$3.37M 0.17% 64

Other funds holding TECH

Grandeur Peak Global Advisors's TECH Position: Q1 2026 in Review

Grandeur Peak Global Advisors reduced its Bio-Techne (TECH) stake by 14% in Q1 2026, selling an estimated $1.35M and leaving 135,646 shares worth $7.09M. The position accounts for 1.66% of the portfolio, ranked #14.

Grandeur Peak Global Advisors first reported a position in TECH in Q3 2022 and has held it in 15 quarters since. The position peaked at $9.3M in Q4 2025. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Grandeur Peak Global Advisors held 135,646 shares of Bio-Techne worth $7.09M as of Q1 2026.
  • Grandeur Peak Global Advisors sold 22,547 Bio-Techne shares in Q1 2026, an estimated $1.35M.
  • Bio-Techne made up 1.66% of Grandeur Peak Global Advisors's portfolio in Q1 2026, its #14 holding.
  • Grandeur Peak Global Advisors first reported a position in Bio-Techne in Q3 2022 and has held it in 15 quarters since.
  • Grandeur Peak Global Advisors's Bio-Techne position peaked at $9.3M in Q4 2025.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Grandeur Peak Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.